Want to see CVS full AI Analyst Report?
CVS Stock Chart & Stats
$77.30
-$0.04(-0.09%)
At close: 4:00 PM EST
$77.30
-$0.04(-0.09%)
Day’s Range― - ―
52-Week Range$58.50 - $106.15
Previous CloseN/A
Volume5.40M
Average Volume (3M)7.70M
Market Cap
$131.18B
Enterprise Value$195.32B
Total Cash (Recent Filing)$11.80B
Total Debt (Recent Filing)$78.34B
Price to Earnings (P/E)45.0
Beta0.52
Next Earnings
Aug 05, 2026EPS Estimate
1.83Next Dividend Ex-DateN/A
Dividend Yield3.41%
Share Statistics
EPS (TTM)2.31
Shares Outstanding1,275,927,200
10 Day Avg. Volume5,749,717
30 Day Avg. Volume7,702,687
Financial Highlights & Ratios
PEG Ratio-0.92
Price to Book (P/B)1.34
Price to Sales (P/S)0.25
P/FCF Ratio12.88
Enterprise Value/Market Cap1.49
Enterprise Value/Revenue0.48
Enterprise Value/Gross Profit3.45
Enterprise Value/Ebitda17.55
Forecast
1Y Price Target
$106.41Price Target Upside37.66% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering18
EPS Forecast (FY)7.42
Revenue Forecast (FY)$408.18B
Bulls Say, Bears Say
Bulls Say
Vertical Integration & ScaleCVS’s integrated model (Aetna + Caremark + retail pharmacy) creates durable competitive advantages: it can retain members, steer pharmacy volume to owned channels, and run care-management programs that lower medical costs. These structural synergies support margin resilience and cross-segment cash generation over multiple years.
Strong Cash GenerationConsistent operating cash flow and meaningful free cash flow provide lasting flexibility to fund investments (technology/AI, Oak Street), pay dividends, and accelerate deleveraging. Even with FCF below peak, the ability to generate multi-billion cash flows underpins capital allocation and strategic initiatives over a 2–6 month horizon and beyond.
Aetna Margin Recovery & OpsMaterial AOI improvement and a markedly lower medical benefit ratio at Aetna reflect durable operational and underwriting progress. Restoring insurance margins improves enterprise profitability structurally, reduces sensitivity to drug/price shocks, and enhances the insurer's ability to fund care initiatives that lower long-term medical cost trends.
Bears Say
Compressed Profitability & Weak ROEProfitability and return on equity have materially declined versus prior years, reflecting structural margin pressure across segments. Low net margins and depressed ROE limit internal reinvestment capacity, constrain the pace of balance‑sheet repair, and make the company more vulnerable to macro cost shocks or prolonged reimbursement pressure.
PBM Margin & Regulatory HeadwindsRebate guarantees, client price pushes and state/federal regulatory actions create persistent margin risk for the PBM franchise. Given PBM scale is a core earnings driver, ongoing regulatory scrutiny and state fragmentation can structurally compress spreads and create multi‑period revenue and AOI volatility.
Membership Loss & Medical Cost TrendsA sequential drop in medical membership from the exchange exit reduces premium scale and dilutes risk pooling benefits. Persistently elevated medical cost trends raise expected medical benefit ratios, pressuring insurance margins and making sustainable underwriting profitability harder without material pricing or utilization improvements.
CVS Health News
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was $58.50 and its highest was $106.15 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is $131.18B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Aug 05, 2026 which is in 25 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on May 06, 2026. The company reported $2.57 earnings per share for the quarter, beating the consensus estimate of $2.184 by $0.386.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of $0.665 which represents an annual dividend yield of 3.41%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.83.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,275,927,200 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of $2.57 in its last earnings report, beating expectations of $2.184. Following the earnings report the stock price went up 7.647%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in CVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$106.41 (37.66% Upside)
$106.41 (37.66% Upside)
Blogger Sentiment
Bullish
CVS Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 18.9M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $323.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.7%
Last 30 Days ▲ 1.0%
Last 30 Days ▲ 1.0%
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Positive
20 days / 200 days
Momentum
64.52%
12-Months-Change
Fundamentals
Return on Equity
3.87%
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
CVS Company Deck
CVS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a generally positive tone driven by clear top-line growth, strong cash generation, profit and EPS beats, an upward revision to full-year EPS guidance, meaningful improvement at Aetna (material AOI gain and operational efficiencies), and ongoing technology/AI initiatives (Health100). Offsetting risks include segment-level profit declines (Health Services and PCW), membership impacts from the Individual Exchange exit, continued elevated medical cost trends, PBM rebate pressures and regulatory/state-level uncertainty. On balance, the favorable operating metrics, raised guidance, and credible path to margin recovery outweighed the identifiable challenges.View all CVS earnings summariesCVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
CVS Stock 12 Month Forecast
Average Price Target
$106.41
▲(37.66% Upside)
Technical Analysis
Ownership Overview
0.41% Insiders
32.79% Mutual Funds
0.57% Other Institutional Investors
44.01% Public Companies and Individual Investors